Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Fractyl Health, Inc. Common Stock

GUTS
Current price
2.09 USD -0.26 USD (-11.06%)
Last closed 2.43 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 133 716 888 USD
Yield for 12 month -86.07 %
1Y
3Y
5Y
10Y
15Y
GUTS
21.11.2021 - 28.11.2021

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts. Address: 3 Van de Graaff Drive, Burlington, MA, United States, 01803

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.5 USD

P/E ratio

Dividend Yield

Current Year

+120 000 USD

Last Year

Current Quarter

+43 000 USD

Last Quarter

+33 000 USD

Current Year

-243 000 USD

Last Year

-452 000 USD

Current Quarter

-173 000 USD

Last Quarter

-39 000 USD

Key Figures GUTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -71 014 000 USD
Operating Margin TTM -53453.49 %
PE Ratio
Return On Assets TTM -48.23 %
PEG Ratio
Return On Equity TTM -169.24 %
Wall Street Target Price 15.5 USD
Revenue TTM 119 000 USD
Book Value 1.48 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -40.3 %
Dividend Yield
Gross Profit TTM
Earnings per share -1.37 USD
Diluted Eps TTM -1.37 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GUTS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GUTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GUTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 777.3271
Price Sales TTM 1123.6714
Enterprise Value EBITDA
Price Book MRQ 1.8899

Financials GUTS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GUTS

For 52 weeks

1.74 USD 15 USD
50 Day MA 3.34 USD
Shares Short Prior Month 1 867 249
200 Day MA 5.9 USD
Short Ratio 2.72
Shares Short 1 897 747
Short Percent 7.16 %